Larry L. Wood - 10 Dec 2021 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP, TAVR
Signature
Linda J. Park, Attorney-in-Fact
Issuer symbol
EW
Transactions as of
10 Dec 2021
Net transactions value
-$675,677
Form type
4
Filing time
10 Dec 2021, 19:41:10 UTC
Previous filing
10 Nov 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $275,590 +7,830 +4% $35.20 205,262 10 Dec 2021 Direct F1, F2
transaction EW Common Stock Sale $951,267 -7,830 -3.8% $121.49 197,432 10 Dec 2021 Direct F1
holding EW Common Stock 496 10 Dec 2021 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -7,830 -100% $0.000000* 0 10 Dec 2021 Common Stock 7,830 $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 29, 2021.
F2 Represents shares transferred to the reporting person's ex-spouse pursuant to a divorce judgement. The securities owned by the ex-spouse are not beneficially owned by the reporting person.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.